|
|
Other links at Articles > Orthopedics |
| 3. |
Oral Bisphosphonate Use Linked to Jaw Osteonecrosis
|
|
|
Oral treatment with the bisphosphonate alendronate (Fosamax, Merck) for as little as 1 year increases the risk for osteonecrosis of the jaw following certain dental procedures, according to a study conducted at the University of Southern California School of Dentistry in Los Angeles. Reuters Health Information
|
|
|